Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 191

1.

[Adverse vaccination reaction does not automatically count as an occupational injury].

[No authors listed]

MMW Fortschr Med. 2015 Sep 10;157(15):11. doi: 10.1007/s15006-015-3447-x. German. No abstract available.

PMID:
26349701
2.

Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.

Saariaho AH, Vuorela A, Freitag TL, Pizza F, Plazzi G, Partinen M, Vaarala O, Meri S.

J Autoimmun. 2015 Sep;63:68-75. doi: 10.1016/j.jaut.2015.07.006. Epub 2015 Jul 27.

PMID:
26227560
3.

Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.

Ghaderi S, Gunnes N, Bakken IJ, Magnus P, Trogstad L, Håberg SE.

Eur J Epidemiol. 2016 Jan;31(1):67-72. doi: 10.1007/s10654-015-0047-0. Epub 2015 May 26.

PMID:
26008750
4.

Deaths following vaccination: What does the evidence show?

Miller ER, Moro PL, Cano M, Shimabukuro TT.

Vaccine. 2015 Jun 26;33(29):3288-92. doi: 10.1016/j.vaccine.2015.05.023. Epub 2015 May 23. Review.

5.

Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.

Iqbal S, Li R, Gargiullo P, Vellozzi C.

Vaccine. 2015 Apr 21;33(17):2045-9. doi: 10.1016/j.vaccine.2015.02.064. Epub 2015 Mar 4.

PMID:
25749247
6.

Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.

Kim C, Rhie S, Suh M, Kang DR, Choi YJ, Bae GR, Choi YC, Jun BY, Lee JS.

Vaccine. 2015 Apr 8;33(15):1815-23. doi: 10.1016/j.vaccine.2015.02.035. Epub 2015 Feb 26.

PMID:
25728315
7.

Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndrome.

Hawken S, Kwong JC, Deeks SL, Crowcroft NS, McGeer AJ, Ducharme R, Campitelli MA, Coyle D, Wilson K.

Emerg Infect Dis. 2015 Feb;21(2):224-31. doi: 10.3201/eid2102.131879.

8.

Responding to vaccine safety signals during pandemic influenza: a modeling study.

Maro JC, Fryback DG, Lieu TA, Lee GM, Martin DB.

PLoS One. 2014 Dec 23;9(12):e115553. doi: 10.1371/journal.pone.0115553. eCollection 2014.

9.

In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.

McGarvey PB, Suzek BE, Baraniuk JN, Rao S, Conkright B, Lababidi S, Sutherland A, Forshee R, Madhavan S.

BMC Immunol. 2014 Dec 9;15:61. doi: 10.1186/s12865-014-0061-0.

10.

Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.

Ropero-Álvarez AM, Whittembury A, Bravo-Alcántara P, Kurtis HJ, Danovaro-Holliday MC, Velandia-González M.

Vaccine. 2015 Jan 1;33(1):187-92. doi: 10.1016/j.vaccine.2014.10.070. Epub 2014 Nov 6.

11.

Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events.

Nordin JD, Kharbanda EO, Vazquez-Benitez G, Lipkind H, Lee GM, Naleway AL.

Vaccine. 2014 Sep 3;32(39):4985-92. doi: 10.1016/j.vaccine.2014.07.017. Epub 2014 Jul 18.

PMID:
25045808
12.

Neurological events related to influenza A (H1N1) pdm09.

Cárdenas G, Soto-Hernández JL, Díaz-Alba A, Ugalde Y, Mérida-Puga J, Rosetti M, Sciutto E.

Influenza Other Respir Viruses. 2014 May;8(3):339-46. doi: 10.1111/irv.12241. Review.

13.

Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.

Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B; GBS Study Group.

Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1192-204. doi: 10.1002/pds.3638. Epub 2014 May 10.

14.

Influenza vaccination and Guillain-Barré syndrome.

Kwong JC, Crowcroft NS, Wilson K, McGeer AJ, Deeks SL.

Lancet Infect Dis. 2014 May;14(5):369-70. doi: 10.1016/S1473-3099(14)70716-9. No abstract available.

PMID:
24758991
15.

Influenza vaccination and Guillain-Barré syndrome.

Giovanetti F.

Lancet Infect Dis. 2014 May;14(5):368. doi: 10.1016/S1473-3099(14)70714-5. No abstract available.

PMID:
24758990
16.

Influenza vaccination and Guillain-Barré syndrome.

Wiznitzer M.

Lancet Infect Dis. 2014 May;14(5):368-9. doi: 10.1016/S1473-3099(14)70715-7. No abstract available.

PMID:
24758989
17.

Influenza vaccinations and chemosensory function.

Doty RL, Berman AH, Izhar M, Hamilton HB, Villano D, Vazquez BE, Warrum MN, Mahbob M.

Am J Rhinol Allergy. 2014 Jan-Feb;28(1):50-3. doi: 10.2500/ajra.2014.28.3987.

PMID:
24717882
18.

Immunogenicity and safety of a trivalent inactivated 2010-2011 influenza vaccine in Taiwan infants aged 6-12 months.

Hwang KP, Hsu YL, Hsieh TH, Lin HC, Yen TY, Wei HM, Lin HC, Chen AC, Chow JC, Huang LM.

Vaccine. 2014 May 1;32(21):2469-73. doi: 10.1016/j.vaccine.2014.02.078. Epub 2014 Mar 10.

PMID:
24625341
19.

Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.

Verity C, Stellitano L, Winstone AM, Stowe J, Andrews N, Miller E.

Arch Dis Child. 2014 Jun;99(6):532-8. doi: 10.1136/archdischild-2013-304475. Epub 2014 Feb 28.

PMID:
24585755
20.

Re: "Chart-confirmed Guillain-Barré syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010".

Stang A.

Am J Epidemiol. 2014 Mar 1;179(5):660. doi: 10.1093/aje/kwt434. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk